SVNS — Solvonis Therapeutics Share News
0.000.00%
Last trade - 00:00- £11.23m
- £10.47m
REG - Solvonis Therapeutic - Synthesis of development candidate for SVN-SDN-014
AnnouncementREG - Solvonis Therapeutic - Notice of Annual General Meeting
AnnouncementREG - Solvonis Therapeutic - Appointment of Prof. David Nutt as CSO
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Total Voting Rights
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementRCS - Solvonis Therapeutic - Presentation at Mello2025
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Completion of the acquisition of Awakn
AnnouncementREG - Solvonis Therapeutic - Publication of a Prospectus
AnnouncementREG - Solvonis Therapeutic - Result of placing
AnnouncementREG - Solvonis Therapeutic - Proposed equity fundraising via ABB
AnnouncementREG - Solvonis Therapeutic - Result of General Meeting
AnnouncementREG - Solvonis Therapeutic - Proposed acquisition of Awakn approved
AnnouncementREG - Solvonis Therapeutic - Final Results for the year ended 31 December 2024
AnnouncementREG - Solvonis Therapeutic - Posting of Circular and Notice of General Meeting
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
Announcement